These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 25755752)
21. Prognostic factors in surgical resection of sacral chordoma. Angelini A; Pala E; Calabrò T; Maraldi M; Ruggieri P J Surg Oncol; 2015 Sep; 112(4):344-51. PubMed ID: 26238085 [TBL] [Abstract][Full Text] [Related]
22. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710 [TBL] [Abstract][Full Text] [Related]
23. Changes in tumor volume of sacral chordoma after carbon ion radiotherapy. Serizawa I; Imai R; Kamada T; Tsuji H; Kishimoto R; Kandatsu S; Tsujii H; Tatezaki S J Comput Assist Tomogr; 2009; 33(5):795-8. PubMed ID: 19820514 [TBL] [Abstract][Full Text] [Related]
24. Analysis of the Infiltrative Features of Chordoma: The Relationship Between Micro-Skip Metastasis and Postoperative Outcomes. Akiyama T; Ogura K; Gokita T; Tsukushi S; Iwata S; Nakamura T; Matsumine A; Yonemoto T; Nishida Y; Saita K; Kawai A; Matsumoto S; Yamaguchi T Ann Surg Oncol; 2018 Apr; 25(4):912-919. PubMed ID: 29181683 [TBL] [Abstract][Full Text] [Related]
25. The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma. Tosuner Z; Bozkurt SU; Kiliç T; Yilmaz B Turk Patoloji Derg; 2017; 33(2):112-120. PubMed ID: 28272674 [TBL] [Abstract][Full Text] [Related]
26. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study. Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340 [TBL] [Abstract][Full Text] [Related]
27. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634 [TBL] [Abstract][Full Text] [Related]
28. Primary chordomas of the cervical spine: a consecutive series of 14 surgically managed cases. Wang Y; Xiao J; Wu Z; Huang Q; Huang W; Zhu Q; Lin Z; Wang L J Neurosurg Spine; 2012 Oct; 17(4):292-9. PubMed ID: 22920610 [TBL] [Abstract][Full Text] [Related]
29. Hand metastasis from a sacral chordoma. Emori M; Kaya M; Sugita S; Soma T; Sasaki M; Yamashita T Ann R Coll Surg Engl; 2014 Nov; 96(8):e8-11. PubMed ID: 25350167 [TBL] [Abstract][Full Text] [Related]
30. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma. Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378 [TBL] [Abstract][Full Text] [Related]
31. Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. Nishida Y; Kamada T; Imai R; Tsukushi S; Yamada Y; Sugiura H; Shido Y; Wasa J; Ishiguro N Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):110-6. PubMed ID: 20400242 [TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725 [TBL] [Abstract][Full Text] [Related]
33. Sacral chordoma: 40-year experience at a major cancer center. York JE; Kaczaraj A; Abi-Said D; Fuller GN; Skibber JM; Janjan NA; Gokaslan ZL Neurosurgery; 1999 Jan; 44(1):74-9; discussion 79-80. PubMed ID: 9894966 [TBL] [Abstract][Full Text] [Related]
34. Biological and prognostic relevance of mitogen-activated protein kinases in pancreatic adenocarcinoma. Handra-Luca A; Lesty C; Hammel P; Sauvanet A; Rebours V; Martin A; Fagard R; Fléjou JF; Faivre S; Bédossa P; Ruszniewski P; Couvelard A Pancreas; 2012 Apr; 41(3):416-21. PubMed ID: 22158075 [TBL] [Abstract][Full Text] [Related]
35. ADAM10 Is a Potential Novel Prognostic Biomarker for Sacral Chordoma. Ding Y; Bui MM; Wang Q; Sun X; Zhang M; Niu X; Tian W Ann Clin Lab Sci; 2019 May; 49(3):309-316. PubMed ID: 31308029 [TBL] [Abstract][Full Text] [Related]
36. Oncologic and functional outcome following sacrectomy for sacral chordoma. Hulen CA; Temple HT; Fox WP; Sama AA; Green BA; Eismont FJ J Bone Joint Surg Am; 2006 Jul; 88(7):1532-9. PubMed ID: 16818979 [TBL] [Abstract][Full Text] [Related]
37. The surgical management of sacral chordomas. Schwab JH; Healey JH; Rose P; Casas-Ganem J; Boland PJ Spine (Phila Pa 1976); 2009 Nov; 34(24):2700-4. PubMed ID: 19910774 [TBL] [Abstract][Full Text] [Related]
38. Sacral chordoma: do the width of surgical margin and the use of photon/proton radiotherapy affect local disease control? Fujiwara T; Tsuda Y; Stevenson J; Parry M; Jeys L Int Orthop; 2020 Feb; 44(2):381-389. PubMed ID: 31863159 [TBL] [Abstract][Full Text] [Related]
39. A review of the surgical management of sacral chordoma. Kayani B; Hanna SA; Sewell MD; Saifuddin A; Molloy S; Briggs TW Eur J Surg Oncol; 2014 Nov; 40(11):1412-20. PubMed ID: 24793103 [TBL] [Abstract][Full Text] [Related]